跳至主要内容
临床试验/JPRN-UMIN000046120
JPRN-UMIN000046120已完成未知

Improvement of cognitive function by ingestion of cacao flavanol : Double-blind crossover test - Cacao flavanol test: Double-blind crossover test

Shibaura institute of technology0 个研究点目标入组 16 人开始时间: 2021年11月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 64years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Those who currently suffer from any kind of disease and are undergoing drug treatment 2.Those who have or are being treated for symptoms of dementia or other memory disorder diseases. 3.Those who have been taking medication for the purpose of disease treatment in the past month (excluding history of headache, menstrual cramps, common cold, etc.) 4.Those who have a history of or are currently suffering from serious disorders of the liver, kidney, heart, lungs, blood, etc. 5.Those with comorbidities or history of comorbidities in the digestive organs 6.Patients with severe anemia 7.Those with food allergies (especially milk) 8.Women: Pregnant, lactating, or planning to become pregnant during the study period 9.Persons with alcoholism or other mental disorders 10.Those with a smoking habit 11.Those who may change their lifestyle during the study period 12.Those at risk of developing seasonal allergic symptoms such as hay fever during the test period. 13.Those who have been in the habit of taking functional foods, health foods, or supplements containing the ingredients (polyphenols) of the test foods at present or within the past three months, and those who plan to do so during the test period. 14.Those who have been in the habit of taking drugs, functional foods, health foods, or supplements claiming to have cognitive effects at present or within the past three months. 15.Have received hormone replacement therapy within the past 6 months. 16.Those who have been treated with hospitalization within the past 6 months, or those who are scheduled to be hospitalized during the examination period. 17.Those who are currently participating in other human clinical trials, and those who have been participating in other human clinical trials for less than one month. 18.Those who have not yet completed the second dose of COVID-19 vaccine. 19.Others who are judged by the investigator to be inappropriate for this study.

研究者

相似试验